Local health care practitioners say they are seeing an increased interest in a product often touted as a source of relief for everything from arthritis to depression.
CBD, or cannabidiol, is a chemical compound of cannibis. In New York State, the CBD sold over the counter is sourced from hemp, and unlike tetrahydrocannabinol (THC) the active ingredient in marijuana, it does not cause a euphoric high.
Sativa Investments (LON:SATI) seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.